Molina Healthcare, Inc. (NYSE:MOH) Shares Purchased by Greenleaf Trust

Greenleaf Trust boosted its position in Molina Healthcare, Inc. (NYSE:MOH) by 40.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,552 shares of the company’s stock after acquiring an additional 446 shares during the quarter. Greenleaf Trust’s holdings in Molina Healthcare were worth $452,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Marshall Wace LLP purchased a new position in Molina Healthcare in the second quarter worth $416,000. Algert Global LLC purchased a new position in Molina Healthcare in the second quarter worth $211,000. Sanctuary Advisors LLC acquired a new position in Molina Healthcare during the second quarter worth about $1,077,000. Handelsbanken Fonder AB grew its position in Molina Healthcare by 23.0% during the third quarter. Handelsbanken Fonder AB now owns 14,437 shares of the company’s stock worth $4,974,000 after buying an additional 2,700 shares during the period. Finally, Czech National Bank grew its position in Molina Healthcare by 6.9% during the third quarter. Czech National Bank now owns 11,937 shares of the company’s stock worth $4,113,000 after buying an additional 771 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on MOH. Barclays upped their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a research report on Friday, October 25th. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, October 24th. Truist Financial decreased their target price on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company lifted their target price on shares of Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a research report on Monday, November 4th. Finally, Robert W. Baird cut their target price on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, four have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $359.18.

Molina Healthcare Trading Down 3.0 %

NYSE MOH opened at $315.46 on Wednesday. Molina Healthcare, Inc. has a 12 month low of $272.69 and a 12 month high of $423.92. The company has a 50-day moving average of $298.36 and a 200-day moving average of $318.39. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.54 and a quick ratio of 1.55. The company has a market cap of $18.04 billion, a P/E ratio of 16.02, a P/E/G ratio of 0.96 and a beta of 0.54.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.